Literature DB >> 11080487

Identification of a cellular repressor of transcription of the adenoviral late IVa(2) gene that is unaltered in activity in infected cells.

H J Lin1, S J Flint.   

Abstract

The gene encoding the adenovirus type 2 IVa(2) protein, a sequence-specific activator of transcription from the viral major late promoter, is itself transcribed only during the late phase of infection. We previously identified a cellular protein (IVa(2)-RF) that binds specifically to an intragenic sequence of the IVa(2) transcription unit. We now report that precise substitutions within the IVa(2)-RF-binding site that decreased binding affinity increased the efficiency of IVa(2) transcription in in vitro reactions containing IVa(2)-RF. Consistent with the conclusion that this cellular protein represses IVa(2) transcription, mutations that led to more efficient transcription in the presence of IVa(2)-RF were without effect in reactions lacking this cellular protein. No change in the concentration or activity of IVa(2)-RF could be detected in adenovirus-infected cells during the period in which the IVa(2) gene is transcribed. We therefore propose that restriction of IVa(2) transcription to the late phase is the result of titration of this cellular repressor as the number of copies of the IVa(2) promoter increases upon replication of the viral genome. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11080487     DOI: 10.1006/viro.2000.0598

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Viral DNA synthesis-dependent titration of a cellular repressor activates transcription of the human adenovirus type 2 IVa2 gene.

Authors:  C Iftode; S J Flint
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-09       Impact factor: 11.205

2.  The adenovirus L4 33-kilodalton protein binds to intragenic sequences of the major late promoter required for late phase-specific stimulation of transcription.

Authors:  Humayra Ali; Gary LeRoy; Gemma Bridge; S J Flint
Journal:  J Virol       Date:  2006-11-08       Impact factor: 5.103

3.  Adenovirus serotype 5 L4-22K and L4-33K proteins have distinct functions in regulating late gene expression.

Authors:  Susan J Morris; Keith N Leppard
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

4.  E1B-55K Is a Phosphorylation-Dependent Transcriptional and Posttranscriptional Regulator of Viral Gene Expression in Human Adenovirus C5 Infection.

Authors:  Paloma Hidalgo; Yasel Garcés; Eduardo Mundo; Raúl E López; Luca D Bertzbach; Thomas Dobner; Ramón A González
Journal:  J Virol       Date:  2022-01-12       Impact factor: 6.549

5.  Adenovirus type 5 exerts genome-wide control over cellular programs governing proliferation, quiescence, and survival.

Authors:  Daniel L Miller; Chad L Myers; Brenden Rickards; Hilary A Coller; S Jane Flint
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

6.  The Human Adenovirus Type 5 L4 Promoter Is Negatively Regulated by TFII-I and L4-33K.

Authors:  Jordan Wright; Zeenah Atwan; Susan J Morris; Keith N Leppard
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

7.  Prognostic role of ARID1A negative expression in gastric cancer.

Authors:  Mai Ashizawa; Motonobu Saito; Aung Kyi Thar Min; Daisuke Ujiie; Katsuharu Saito; Takahiro Sato; Tomohiro Kikuchi; Hirokazu Okayama; Shotaro Fujita; Hisahito Endo; Wataru Sakamoto; Tomoyuki Momma; Shinji Ohki; Akiteru Goto; Koji Kono
Journal:  Sci Rep       Date:  2019-05-01       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.